Literature DB >> 25937730

Internal jugular vein thrombosis due to heterozygote methylene tetrahydrofolate reductase (MTHFR) 1298C and Factor V G1691A mutations after a minor trauma.

Murat Gumussoy1, Ilker B Arslan1, Ibrahim Cukurova1, Sinan Uluyol1.   

Abstract

Internal jugular vein thrombosis usually appears in central venous catheterization, distant malignancies, hypercoagulation, infections, or secondary to ovarian hyperstimulation syndrome. A 44-year-old female patient presented to us with sore throat, and pain and swelling on the right side of her neck. She had a history of simple neck trauma 10 days ago. Ultrasonography and computed tomography showed bilateral multiple lymphadenopathies and right internal jugular vein thrombosis. Patient was put on parenteral antibiotherapy and oral anticoagulant treatment. Genomic DNA tests for hypercoagulation revealed methylene tetrahydrofolate reductase 1298C heterozygote mutation and Factor V G1691A (Leiden) mutation. Patient has been under clinical control for 1 year and does not have any complaints. In this article, diagnosis, treatment, and the etiology of internal jugular vein thrombosis, which is a rare and potentially fatal condition, have been discussed through this case.

Entities:  

Keywords:  Factor V; internal jugular vein thrombosis; methylene tetrahydrofolate reductase 1298C; thrombophilia

Year:  2014        PMID: 25937730      PMCID: PMC4405961          DOI: 10.4103/0975-5950.154824

Source DB:  PubMed          Journal:  Natl J Maxillofac Surg        ISSN: 0975-5950


  15 in total

Review 1.  Superior mediastinal and internal jugular venous thrombosis presenting to the otolaryngologist.

Authors:  Carmen De Casso; Sudip Ghosh; Michael Timms; Pradeep Morar
Journal:  J Laryngol Otol       Date:  2005-01       Impact factor: 1.469

2.  Internal jugular vein thrombosis.

Authors:  D C Duffey; K R Billings; B S Eichel; J A Sercarz
Journal:  Ann Otol Rhinol Laryngol       Date:  1995-11       Impact factor: 1.547

Review 3.  Neck masses in children.

Authors:  J R A Turkington; A Paterson; L E Sweeney; G D Thornbury
Journal:  Br J Radiol       Date:  2005-01       Impact factor: 3.039

4.  Thrombophilia and venous thromboembolism. International consensus statement. Guidelines according to scientific evidence.

Authors:  A N Nicolaides; H K Breddin; P Carpenter; S Coccheri; J Conard; V De Stefano; N Elkoofy; G Gerotziafas; S Guermazi; S Haas; R Hull; E kalodiki; V Kristof; J J Michiels; K Myers; G Pineo; P Prandoni; G Romeo; M M Samama; S Simonian; S Xenophonthos
Journal:  Int Angiol       Date:  2005-03       Impact factor: 2.789

5.  The advantages of MRI and MRA for diagnosing Behçet's disease and internal jugular vein thrombosis.

Authors:  M Danaci; T Akpolat; M Koyuncu; R Unal; U Belet
Journal:  Comput Med Imaging Graph       Date:  2000 Mar-Apr       Impact factor: 4.790

6.  The G20210A mutation of the prothrombin gene in patients with previous first episodes of deep-vein thrombosis: prevalence and association with factor V G1691A, methylenetetrahydrofolate reductase C677T and plasma prothrombin levels.

Authors:  M Cattaneo; V Chantarangkul; E Taioli; J H Santos; L Tagliabue
Journal:  Thromb Res       Date:  1999-01-01       Impact factor: 3.944

7.  A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase.

Authors:  P Frosst; H J Blom; R Milos; P Goyette; C A Sheppard; R G Matthews; G J Boers; M den Heijer; L A Kluijtmans; L P van den Heuvel
Journal:  Nat Genet       Date:  1995-05       Impact factor: 38.330

8.  Lemierre's syndrome associated with septic pulmonary embolism: a case report.

Authors:  Niyazi Gormus; Kadir Durgut; Ufuk Ozergin; Kemal Odev; Hasan Solak
Journal:  Ann Vasc Surg       Date:  2004-03       Impact factor: 1.466

9.  Spontaneous jugular vein thrombosis.

Authors:  Jaromír Chlumský; Jan Havlín
Journal:  Acta Cardiol       Date:  2009-10       Impact factor: 1.718

10.  Spontaneous internal jugular vein thrombosis associated with distant malignancies.

Authors:  Elvan Evrim Unsal; Cíhan Karaca; Serdar Ensarí
Journal:  Eur Arch Otorhinolaryngol       Date:  2002-08-21       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.